Ryan Fukushima, Pathos AI CEO
May 2, 2025 10:55 AM EDT
Financing
Startups
AI

Pathos AI gets As­traZeneca fund­ing as biotech plans to raise up to $400M

Kyle LaHucik

Senior Reporter

Pathos AI, a Chica­go biotech led by ex­ec­u­tives of the health­care AI group Tem­pus, is look­ing at a fund­ing round of up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Ex­clu­sive: Ver­tex drops AAV gene ther­a­py re­search, tR­NA ther­a­py part­ner­ship

Ex­clu­sive: Af­ter FDA fir­ings, drug re­view­ers are asked to vol­un­teer for ad­min­is­tra­tive work

Drug­mak­ers ex­ploit can­cer’s ‘lethal­i­ties’ to make next class of tar­get­ed ther­a­pies, with first re­sults for ...

FDA with­draws two fi­nal guid­ances, pulls com­pli­ance dead­lines for bone al­lo­graft mak­ers

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times